Matyas G R, Morré D J
Department of Biological Sciences, Purdue University, West Lafayette, IN 47907.
Biochim Biophys Acta. 1987 Oct 17;921(3):599-614. doi: 10.1016/0005-2760(87)90089-0.
Gangliosides have generally been assumed to be localized primarily in the plasma membrane. Analysis of gangliosides from isolated subcellular membrane fractions of rat liver indicated that 76% of the total ganglioside sialic acid was present in the plasma membrane. Mitochondria and endoplasmic reticulum fractions, while containing only low levels of gangliosides on a protein basis, each contained approx. 10% of total ganglioside sialic acid. Gangliosides also were present in the Golgi apparatus and nuclear membrane fractions, and soluble gangliosides were in the supernatant. Individual gangliosides were non-homogeneously distributed and each membrane fraction was characterized by a unique ganglioside composition. Plasma membrane contained only 14 and 28% of the total GD1a and GD3, respectively, but 80-90% of the GM1, GD1b, GT1b and GQ1b. Endoplasmic reticulum, when corrected for plasma membrane contamination, contained only trace amounts of GM1, GD1b, GT1b and GQ1b, but 11 and 5% of the total GD1a and GD3, respectively. The ganglioside composition of highly purified endoplasmic reticulum was similar. Ganglioside biosynthetic enzymes were concentrated in the Golgi apparatus. However, low levels of these enzymes were present in the highly purified endoplasmic reticulum fractions. Pulse-chase experiments with [3H]galactose revealed that total gangliosides were labeled first in the Golgi apparatus, mitochondria and supernatant within 10 min. Labeled gangliosides were next observed at 30 min in the endoplasmic reticulum, plasma membrane and nuclear membrane fractions. Analysis of the individual gangliosides also revealed that GM3, GM1, GD1a and GD1b were labeled first in the Golgi apparatus at 10 min. These studies indicate that gangliosides synthesized in the Golgi apparatus may be transported not only to the plasma membrane, but to the endoplasmic reticulum and to other internal endomembranes as well.
神经节苷脂一般被认为主要定位于质膜。对大鼠肝脏分离的亚细胞膜组分中的神经节苷脂进行分析表明,总神经节苷脂唾液酸的76%存在于质膜中。线粒体和内质网组分,虽然以蛋白质为基础仅含有低水平的神经节苷脂,但各自含有约10%的总神经节苷脂唾液酸。神经节苷脂也存在于高尔基体和核膜组分中,可溶性神经节苷脂存在于上清液中。单个神经节苷脂分布不均一,每个膜组分都有独特的神经节苷脂组成特征。质膜分别仅含有总GD1a和GD3的14%和28%,但含有80 - 90%的GM1、GD1b、GT1b和GQ1b。内质网经质膜污染校正后,仅含有痕量的GM1、GD1b、GT1b和GQ1b,但分别含有总GD1a和GD3的11%和5%。高度纯化的内质网的神经节苷脂组成相似。神经节苷脂生物合成酶集中在高尔基体中。然而,在高度纯化的内质网组分中也存在低水平的这些酶。用[3H]半乳糖进行的脉冲追踪实验表明,总神经节苷脂在10分钟内首先在高尔基体、线粒体和上清液中被标记。30分钟后在内质网、质膜和核膜组分中观察到标记的神经节苷脂。对单个神经节苷脂的分析还表明,GM3、GM1、GD1a和GD1b在10分钟时首先在高尔基体中被标记。这些研究表明,在高尔基体中合成的神经节苷脂不仅可能被转运到质膜,也可能被转运到内质网和其他内部内膜。